← Back to home

INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL)

Clinical trials for INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL) explained in plain language.

Never miss a new study

Get alerted when new INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL) trials appear

Sign up with your email to follow new studies for INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New CAR-T therapy aims to fight tough lymphoma

Disease control Not yet recruiting

This early-phase study tests a new treatment called CY-219 CAR-T cells in 18 people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified to target and kill cancer cells. The main goals are to check…

Matched conditions: INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL)

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL)

Get alerted when new INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL) trials appear

New CAR-T therapy aims to fight tough lymphoma